Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized placebo-controlled study of Triferic delivered via dialysate in Chinese patients with CKD on maintenance hemodialysis
CTR20202200Phase 3Active
- Sponsor
- Rockwell Medical
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric pyrophosphate in chronic kidney disease (CKD), sponsored by Rockwell Medical. Started Jan 2021; status: active.
02
Drugs
ferric pyrophosphate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20202200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202200.